The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
IPO Year: n/a
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|
VanEck announced today the following 2024 annual distributions per share for its VanEck® equity exchange-traded funds. Distributions Per Share for the VanEck ETFs Listed Below Ex-Date: December 23, 2024 | Record Date: December 23, 2024 | Payable Date: December 24, 2024 Fund Ticker Income Approximate % of Income from PFICs Short-Term Capital Gain Long-Term Capital Gain VanEck Africa Index ETF AFK None None None None VanEck Biotech ETF BBH $ 1.2517 22% None None VanEck Gaming ETF BJK $ 1.1667 34% None None VanEck Brazil Small-Cap
VanEck announced today the following 2024 annual distributions per share for its VanEck® equity exchange-traded funds. Distributions Per Share for the VanEck ETFs Listed Below Ex-Date: December 23, 2024 | Record Date: December 23, 2024 | Payable Date: December 24, 2024 Fund Ticker Income Approximate % of Income from PFICs Short-Term Capital Gain Long-Term Capital Gain VanEck Africa Index ETF AFK None None None None VanEck Biotech ETF BBH $ 1.2517 22% None None VanEck Gaming ETF BJK $ 1.1667 34% None None VanEck Brazil Small-Cap